New genomic technologies: An aid for diagnosis of disorders of sex development

Hormone and Metabolic Research

Volumn 47, Issue 5, 2015, Pages 312-320

  Barseghyan, H ^a   Delot E ^a   Vilain, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DSD; exome sequencing; gonadal dysgenesis; microarray; sex development

Indexed keywords

CLINICAL PRACTICE; CLONING; DISORDER OF SEX DEVELOPMENT; EXOME; GENETIC IDENTIFICATION; GENOMICS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MEDICAL TECHNOLOGY; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; STANDARDIZATION; DISORDERS OF SEX DEVELOPMENT; GENETICS; PROCEDURES;

DISORDERS OF SEX DEVELOPMENT; GENOMICS; HUMANS;

EID: 84929319810     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0035-1548831     Document Type: Review

References (60)

1. Berta P., Hawkins J. R., Sinclair A. H., Taylor A., Griffiths B. L., Goodfellow P. N., Fellous M. Genetic evidence equating SRY and the testis-determining factor. Nature: 1990; 348 448 450
2. Koopman P., Gubbay J., Vivian N., Goodfellow P. N., Lovell-Badge R. Male development of chromosomally female mice transgenic for Sry. Nature: 1991; 351 117 121
3. Sinclair A. H., Berta P., Palmer M. S., Hawkins J. R., Griffiths B. L., Smith M. J., Foster J. W., Frischauf A. M., Lovell-Badge R., Goodfellow P. N. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature: 1990; 346 240 244
4. Sekido R., Lovell-Badge R. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature: 2008; 453 930 934
5. Parma P., Radi O., Vidal V., Chaboissier M. C., Dellambra E., Valentini S., Guerra L., Schedl A., Camerino G. R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat Genet: 2006; 38 1304 1309
6. Biason-Lauber A. WNT4, RSPO1, and FOXL2 in sex development. Semin Reprod Med: 2012; 30 387 395
7. Biason-Lauber A., Konrad D., Navratil F., Schoenle E. J. A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman. N Engl J Med: 2004; 351 792 798
8. Jordan B. K., Mohammed M., Ching S. T., Delot E., Chen X. N., Dewing P., Swain A., Rao P. N., Elejalde B. R., Vilain E. Up-regulation of WNT-4 signaling and dosage-sensitive sex reversal in humans. Am J Hum Genet: 2001; 68 1102 1109
9. Barbaro M., Oscarson M., Schoumans J., Staaf J., Ivarsson S. A., Wedell A. Isolated 46,XY gonadal dysgenesis in two sisters caused by a Xp21.2 interstitial duplication containing the DAX1 gene. J Clin Endocrinol Metab: 2007; 92 3305 3313
10. Lee P. A., Houk C. P., Ahmed S. F., Hughes I. A. S. International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine, and E. the European Society for Paediatric, Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics: 2006; 118 e488 e500
11. Lux A., Kropf S., Kleinemeier E., Jurgensen M., Thyen U. D.S.D.N.W. Group Clinical evaluation study of the German network of disorders of sex development (DSD)/intersexuality: study design, description of the study population, and data quality. BMC Public Health: 2009; 9 110
12. Sandberg D. E., Gardner M., Cohen-Kettenis P. T. Psychological aspects of the treatment of patients with disorders of sex development. Semin Reprod Med: 2012; 30 443 452
13. Warne G. L. Long-term outcome of disorders of sex development. Sex Dev: 2008; 2 268 277
14. Cameron F. J., Sinclair A. H. Mutations in SRY and SOX9: testis-determining genes. Hum Mutat: 1997; 9 388 395
15. Hawkins J. R. Mutational analysis of SRY in XY females. Hum Mutat: 1993; 2 347 350
16. Veitia R., Ion A., Barbaux S., Jobling M. A., Souleyreau N., Ennis K., Ostrer H., Tosi M., Meo T., Chibani J., Fellous M., McElreavey K. Mutations and sequence variants in the testis-determining region of the Y chromosome in individuals with a 46,XY female phenotype. Hum Genet: 1997; 99 648 652
17. ® Pagon R. A. (ed.) Seattle (WA) University of Washington: 1993
18. Baxter R. M., Arboleda V. A., Lee H., Barseghyan H., Adam M. P., Fechner P. Y., Bargman R., Keegan C., Travers S., Schelley S., Hudgins L., Mathew R. P., Stalker H. J., Zori R., Gordon O. K., Ramos-Platt L., Pawlikowska-Haddal A., Eskin A., Nelson S. F., Delot E., Vilain E. Exome Sequencing for the Diagnosis of 46,XY Disorders of Sex Development. J Clin Endocrinol Metab: 2015; 100 E333 E344
19. Pearlman A., Loke J., Le Caignec C., White S., Chin L., Friedman A., Warr N., Willan J., Brauer D., Farmer C., Brooks E., Oddoux C., Riley B., Shajahan S., Camerino G., Homfray T., Crosby A. H., Couper J., David A., Greenfield A., Sinclair A., Ostrer H. Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am J Hum Genet: 2010; 87 898 904
20. Délot E., Vilain E. Non-syndromic 46,XX Testicular Disorders of Sex Development. GeneReviews. 2015; [in press]
21. Zenteno-Ruiz J. C., Kofman-Alfaro S., Mendez J. P. 46,XX sex reversal. Arch Med Res: 2001; 32 559 566
22. McElreavey K., Rappaport R., Vilain E., Abbas N., Richaud F., Lortat-Jacob S., Berger R., Le Coniat M., Boucekkine C., Kucheria K., Temtamy S., Nihoul-Fekete C., Brauner R., Fellous M. A minority of 46,XX true hermaphrodites are positive for the Y-DNA sequence including SRY. Hum Genet: 1992; 90 121 125
23. Baxter R. M., Vilain E. Translational genetics for diagnosis of human disorders of sex development. Annu Rev Genomics Hum Genet: 2013; 14 371 392
24. Muscatelli F., Strom T. M., Walker A. P., Zanaria E., Recan D., Meindl A., Bardoni B., Guioli S., Zehetner G., Rabl W., Schwarz H. P., Kaplan J-C, Camerino G., Meitinger T., Monaco A. P. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature: 1994; 372 672 676
25. Bardoni B., Zanaria E., Guioli S., Floridia G., Worley K. C., Tonini G., Ferrante E., Chiumello G., McCabe E. R., Fraccaro M., Zuffardi O., Camerino G. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet: 1994; 7 497 501
26. Ledig S., Hiort O., Scherer G., Hoffmann M., Wolff G., Morlot S., Kuechler A., Wieacker P. Array-CGH analysis in patients with syndromic and non-syndromic XY gonadal dysgenesis: evaluation of array CGH as diagnostic tool and search for new candidate loci. Hum Reprod: 2010; 25 2637 2646
27. White S., Ohnesorg T., Notini A., Roeszler K., Hewitt J., Daggag H., Smith C., Turbitt E., Gustin S., van den Bergen J., Miles D., Western P., Arboleda V., Schumacher V., Gordon L., Bell K., Bengtsson H., Speed T., Hutson J., Warne G., Harley V., Koopman P., Vilain E., Sinclair A. Copy number variation in patients with disorders of sex development due to 46,XY gonadal dysgenesis. PLoS One: 2011; 6 e17793
28. Weiss J., Meeks J. J., Hurley L., Raverot G., Frassetto A., Jameson J. L. Sox3 is required for gonadal function, but not sex determination, in males and females. Mol Cell Biol: 2003; 23 8084 8091
29. Sutton E., Hughes J., White S., Sekido R., Tan J., Arboleda V., Rogers N., Knower K., Rowley L., Eyre H., Rizzoti K., McAninch D., Goncalves J., Slee J., Turbitt E., Bruno D., Bengtsson H., Harley V., Vilain E., Sinclair A., Lovell-Badge R., Thomas P. Identification of SOX3 as an XX male sex reversal gene in mice and humans. J Clin Invest: 2011; 121 328 341
30. Moalem S., Babul-Hirji R., Stavropolous D. J., Wherrett D., Bagli D. J., Thomas P., Chitayat D. XX male sex reversal with genital abnormalities associated with a de novo SOX3 gene duplication. Am J Med Genet A: 2012; 158A 1759 1764
31. Vetro A., Dehghani M. R., Kraoua L., Giorda R., Beri S., Cardarelli L., Merico M., Manolakos E., Bustamante A. P., Castro A., Radi O., Camerino G., Brusco A., Sabaghian M., Sofocleous C., Forzano F., Palumbo P., Palumbo O., Calvano S., Zelante L., Grammatico P., Giglio S., Basly M., Chaabouni M., Carella M., Russo G., Bonaglia M. C., Zuffardi O. Testis development in the absence of SRY: chromosomal rearrangements at SOX9 and SOX3. Eur J Hum Genet: 2014; Nov 5 10.1038/ejhg.2014.237 [Epub ahead of print]
32. White S., Hewitt J., Turbitt E., van der Zwan Y., Hersmus R., Drop S., Koopman P., Harley V., Cools M., Looijenga L., Sinclair A. A multi-exon deletion within WWOX is associated with a 46,XY disorder of sex development. Eur J Hum Genet: 2012; 20 348 351
33. Ludes-Meyers J. H., Kil H., Nunez M. I., Conti C. J., Parker-Thornburg J., Bedford M. T., Aldaz C. M. WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy. Gens Chromosomes Cancer: 2007; 46 1129 1136
34. Lecointre C., Pichon O., Hamel A., Heloury Y., Michel-Calemard L., Morel Y., David A., Le Caignec C. Familial acampomelic form of campomelic dysplasia caused by a 960 kb deletion upstream of SOX9. Am J Med Genet A: 2009; 149A 1183 1189
35. Cox J. J., Willatt L., Homfray T., Woods C. G. A SOX9 duplication and familial 46,XX developmental testicular disorder. N Engl J Med: 2011; 364 91 93
36. Benko S., Gordon C. T., Mallet D., Sreenivasan R., Thauvin-Robinet C., Brendehaug A., Thomas S., Bruland O., David M., Nicolino M., Labalme A., Sanlaville D., Callier P., Malan V., Huet F., Molven A., Dijoud F., Munnich A., Faivre L., Amiel J., Harley V., Houge G., Morel Y., Lyonnet S. Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development. J Med Genet: 2011; 48 825 830
37. Vetro A., Ciccone R., Giorda R., Patricelli M. G., Della Mina E., Forlino A., Zuffardi O. XX males SRY negative: a confirmed cause of infertility. J Med Genet: 2011; 48 710 712
38. Kim G. J., Sock E., Buchberger A., Just W., Denzer F., Hoepffner W., German J., Cole T., Mann J., Seguin J. H., Zipf W., Costigan C., Schmiady H., Rostasy M., Kramer M., Kaltenbach S., Rosler B., Georg I., Troppmann E., Teichmann A. C., Salfelder A., Widholz S. A., Wieacker P., Hiort O., Camerino G., Radi O., Wegner M., Arnold H. H., Scherer G. Copy number variation of two separate regulatory regions upstream of SOX9 causes isolated 46,XY or 46,XX disorder of sex development. J Med Genet: 2015; 52 240 247
39. Quinonez S. C., Park J. M., Rabah R., Owens K. M., Yashar B. M., Glover T. W., Keegan C. E. 9p partial monosomy and disorders of sex development: review and postulation of a pathogenetic mechanism. Am J Med Genet A: 2013; 161A 1882 1896
40. Igarashi M., Dung V. C., Suzuki E., Ida S., Nakacho M., Nakabayashi K., Mizuno K., Hayashi Y., Kohri K., Kojima Y., Ogata T., Fukami M. Cryptic genomic rearrangements in three patients with 46,XY disorders of sex development. PLoS One: 2013; 8 e68194
41. Tannour-Louet M., Han S., Corbett S. T., Louet J. F., Yatsenko S., Meyers L., Shaw C. A., Kang S. H., Cheung S. W., Lamb D. J. Identification of de novo copy number variants associated with human disorders of sexual development. PLoS One: 2010; 5 e15392
42. Tannour-Louet M., Han S., Louet J. F., Zhang B., Romero K., Addai J., Sahin A., Cheung S. W., Lamb D. J. Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action. Nat Med: 2014; 20 715 724
43. Lee H., Deignan J. L., Dorrani N., Strom S. P., Kantarci S., Quintero-Rivera F., Das K., Toy T., Harry B., Yourshaw M., Fox M., Fogel B. L., Martinez-Agosto J. A., Wong D. A., Chang V. Y., Shieh P. B., Palmer C. G., Dipple K. M., Grody W. W., Vilain E., Nelson S. F. Clinical Exome Sequencing for Genetic Identification of Rare Mendelian Disorders. JAMA: 2014; 312 1880 1887
44. Genomes Project C Abecasis G. R., Altshuler D., Auton A., Brooks L. D., Durbin R. M., Gibbs R. A., Hurles M. E., McVean G. A. A map of human genome variation from population-scale sequencing. Nature: 2010; 467 1061 1073
45. Richards C. S., Bale S., Bellissimo D. B., Das S., Grody W. W., Hegde M. R., Lyon E., Ward B. E. A.L.Q.A.C Molecular Subcommittee of the ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med: 2008; 10 294 300
46. Biesecker L. G., Green R. C. Diagnostic clinical genome and exome sequencing. N Engl J Med: 2014; 370 2418 2425
47. Yang Y., Muzny D. M., Xia F., Niu Z., Person R., Ding Y., Ward P., Braxton A., Wang M., Buhay C., Veeraraghavan N., Hawes A., Chiang T., Leduc M., Beuten J., Zhang J., He W., Scull J., Willis A., Landsverk M., Craigen W. J., Bekheirnia M. R., Stray-Pedersen A., Liu P., Wen S., Alcaraz W., Cui H., Walkiewicz M., Reid J., Bainbridge M., Patel A., Boerwinkle E., Beaudet A. L., Lupski J. R., Plon S. E., Gibbs R. A., Eng C. M. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA: 2014; 312 1870 1879
48. Fogel B. L., Lee H., Deignan J. L., Strom S. P., Kantarci S., Wang X., Quintero-Rivera F., Vilain E., Grody W. W., Perlman S., Geschwind D. H., Nelson S. F. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol: 2014; 71 1237 1246
49. Srivastava S., Cohen J. S., Vernon H., Baranano K., McClellan R., Jamal L., Naidu S., Fatemi A. Clinical whole exome sequencing in child neurology practice. Ann Neurol: 2014; 76 473 483
50. Yang Y., Muzny D. M., Reid J. G., Bainbridge M. N., Willis A., Ward P. A., Braxton A., Beuten J., Xia F., Niu Z., Hardison M., Person R., Bekheirnia M. R., Leduc M. S., Kirby A., Pham P., Scull J., Wang M., Ding Y., Plon S. E., Lupski J. R., Beaudet A. L., Gibbs R. A., Eng C. M. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med: 2013; 369 1502 1511
51. ® Pagon R. A. (ed.) Seattle (WA) University of Washington: 1993
52. Lek N., Miles H., Bunch T., Pilfold-Wilkie V., Tadokoro-Cuccaro R., Davies J., Ong K. K., Hughes I. A. Low frequency of androgen receptor gene mutations in 46 XY DSD, and fetal growth restriction. Arch Dis Child: 2014; 99 358 361
53. El-Khairi R., Achermann J. C. Steroidogenic factor-1 and human disease. Semin Reprod Med: 2012; 30 374 381
54. Philibert P., Paris F., Audran F., Kalfa N., Polak M., Thibaud E., Pinto G., Houang M., Zenaty D., Leger J., Mas J. C., Pienkowski C., Einaudi S., Damiani D., Ten S., Sinha S., Poulat F., Sultan C. Phenotypic variation of SF1 gene mutations. Adv Exp Med Biol: 2011; 707 67 72
55. Allali S., Muller J. B., Brauner R., Lourenco D., Boudjenah R., Karageorgou V., Trivin C., Lottmann H., Lortat-Jacob S., Nihoul-Fekete C., De Dreuzy O., McElreavey K., Bashamboo A. Mutation analysis of NR5A1 encoding steroidogenic factor 1 in 77 patients with 46, XY disorders of sex development (DSD) including hypospadias. PLoS One: 2011; 6 e24117
56. Green R. C., Berg J. S., Grody W. W., Kalia S. S., Korf B. R., Martin C. L., McGuire A. L., Nussbaum R. L., O'Daniel J. M., Ormond K. E., Rehm H. L., Watson M. S., Williams M. S., Biesecker L. G. American College of Medical, and Genomics, ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med: 2013; 15 565 574
57. Allyse M., Michie M. Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing. Trends Biotechnol: 2013; 31 439 441
58. Relations A. M. ACMG Updates Recommendation on Opt Out for Genome Sequencing Return of Results. 2014
59. Loke J., Pearlman A., Radi O., Zuffardi O., Giussani U., Pallotta R., Camerino G., Ostrer H. Mutations in MAP3K1 tilt the balance from SOX9/FGF9 to WNT/beta-catenin signaling. Hum Mol Genet: 2014; 23 1073 1083
60. th edn Amsterdam Saunders Elsevier: 2009; Ch.16 367 393